Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Toyoaki Hida"'
Publikováno v:
Medical Oncology. 34
Nivolumab offers a statistically superior survival benefit over docetaxel in patients with advanced, previously treated squamous and non-squamous non-small-cell lung cancer (NSCLC). However, we unexpectedly encountered “tumor flare” that was asso